John T. Wilson, Ph.D.

Associate Professor
Vanderbilt University
Nashville, Tennessee, United States

Presentation(s):

• Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy

  Thursday, October 12, 2023
  12:30 PM – 12:45 PM PDT

• Mechnoimmunobiology

  Thursday, October 12, 2023
  12:30 PM – 2:00 PM PDT

• Endosomolytic Polymersomes Enhance Intracellular Delivery of Nucleic Acid Therapeutics for Improved Anticancer Immune Responses

  Thursday, October 12, 2023
  12:30 PM – 12:35 PM PDT

• Molecular Immunoengineering

  Thursday, October 12, 2023
  3:00 PM – 4:30 PM PDT

• ROS-responsive, On-Demand Delivery of STING Pathway Inhibitors to Treat Ulcerative Colitis and Reprogram the Immune Microenvironment in the Colon

  Friday, October 13, 2023
  8:45 AM – 9:00 AM PDT

• Systems Immunology

  Friday, October 13, 2023
  8:00 AM – 9:30 AM PDT

• STING-Pathway Inhibiting PLGA Nanoparticles to Treat STING-associated Inflammatory Conditions

  Friday, October 13, 2023
  2:45 PM – 3:00 PM PDT

• Immunostimulatory Nanobody-STING Agonist Conjugates to Improve Immunotherapy

  Friday, October 13, 2023
  2:40 PM – 2:45 PM PDT

• Cellular Immunoengineering

  Friday, October 13, 2023
  4:00 PM – 5:30 PM PDT

• Engineered Immune Models

  Friday, October 13, 2023
  4:00 PM – 5:30 PM PDT

• Immune Regulation and Tolerance

  Friday, October 13, 2023
  4:00 PM – 5:30 PM PDT

• Drug Delivery Systems for Immunomodulation

  Saturday, October 14, 2023
  8:00 AM – 9:30 AM PDT

• Polymer-Drug Conjugates for STING Pathway Activation to Enhance Cancer Immunotherapy

  Saturday, October 14, 2023
  8:30 AM – 8:45 AM PDT

• Albumin-binding nanobody-antigen fusions enhance antigen presentation and improve vaccine responses through pharmacokinetic modulation

  Saturday, October 14, 2023
  12:30 PM – 12:45 PM PDT

• Engineered Vaccines

  Saturday, October 14, 2023
  2:30 PM – 4:00 PM PDT